|
|
|
Transplant Statistics: Annual Report : Reference Tables
| Year of Transplant | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | ||
| Functioning Graft at Discharge | 443 | 597 | 643 | 775 | 704 | 808 | 754 | 804 | 855 | 959 | |
| With Immunosuppression Info | 443 | 596 | 638 | 763 | 633 | 800 | 746 | 792 | 842 | 913 | |
| Corticosteroids | Category Usage | 95.5% | 97.1% | 98.0% | 97.2% | 96.7% | 98.5% | 97.3% | 98.0% | 97.1% | 98.9% |
| Prednisone | 95.3% | 96.3% | 96.1% | 96.3% | 94.8% | 97.0% | 96.1% | 95.6% | 94.9% | 96.4% | |
| Methylprednisolone | 9.5% | 8.1% | 28.4% | 8.0% | 9.2% | 7.1% | 4.0% | 10.2% | 6.2% | 6.5% | |
| Cyclosporine | Category Usage | 89.8% | 91.1% | 92.0% | 74.8% | 69.8% | 74.8% | 73.6% | 66.5% | 62.0% | 50.6% |
| Cyclosporin | 89.6% | 91.1% | 88.1% | 60.8% | 2.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Sandimmmune | 0.2% | 0.5% | 3.8% | 12.6% | 19.4% | 17.0% | 11.8% | 10.9% | 6.8% | 5.8% | |
| Neoral | 0.0% | 0.0% | 0.5% | 3.0% | 49.3% | 59.9% | 63.7% | 59.3% | 56.3% | 40.2% | |
| Gengraf | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.1% | 5.7% | |
| Eon | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.4% | |
| Tacrolimus | Category Usage | 6.3% | 5.9% | 5.2% | 9.0% | 21.0% | 24.6% | 26.5% | 30.2% | 38.2% | 50.5% |
| FK506 | 6.3% | 5.9% | 5.2% | 9.0% | 21.0% | 24.6% | 26.5% | 30.2% | 38.2% | 50.5% | |
| Antimetabolites | Category Usage | 96.6% | 97.8% | 95.9% | 90.6% | 90.4% | 90.6% | 92.2% | 91.5% | 93.2% | 92.3% |
| Azathioprine | 96.6% | 97.8% | 95.6% | 87.4% | 80.7% | 71.9% | 70.1% | 63.9% | 58.6% | 50.7% | |
| Mycophenolate mofetil | 0.0% | 0.0% | 0.3% | 3.7% | 11.4% | 20.9% | 23.9% | 29.2% | 35.3% | 42.6% | |
| Other | Category Usage | 0.0% | 0.3% | 0.3% | 0.1% | 0.0% | 0.5% | 0.3% | 1.0% | 2.7% | 3.9% |
| Rapamycin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.6% | 2.4% | 3.8% | |
| Cytoxan | 0.0% | 0.3% | 0.3% | 0.1% | 0.0% | 0.4% | 0.1% | 0.4% | 0.4% | 0.1% | |
Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline
Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map
SRTR Site designed and maintained by Diamond Bullet Design & URREA.